Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Clinical characteristics of the case group regarding disease duration, widespread pain index, symptoms severity scale and polysymptomatic distress scale are demonstrated in Table 2.Demographic and biochemical characteristics of the study groupsCases(N = 40)Control(N = 40)P valueMean ± SDN (%)Mean ± SDN (%)Age37 ± 935 ± 80.53Sex Male12(30%)10 (25%)0.62 Female28(70%)30(70%)Urea28 ± 1025 ± 110.12Creatinine0.82 ± 0.340.69 ± 0.220.05AST IU/L29 ± 522 ± 7 < 0.001ALT IU/L27 ± 426 ± 50.26vit D ng/ml28.8 ± 4.9TSH mIU/l2.5 ± 9ESR mm/hr10 ± 4CRP mg/dl0.5 ± 0.2AST,aspartate transaminase; ALT, alanine transaminase; vit D, vitamin D; TSH,Thyroid stimulating hormone; ESR., Erythrocyte sedimentation Rate; CRP, C-reactive proteinData are represented as mean ± standard deviation or n (%). * Significant at P < 0.05Clinical characteristics of the case groupMean ± SDMedian (IQR)Disease duration5.3 ± 4.44.0(2 to 6)Widespread pain index12 ± 412(10 to 14)Symptoms severity scale8 ± 39(6 to 11)Polysymptomatic distress scale21 ± 520(17 to 24)

Source: Assessment of the research groups' clinical and demographic characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

According to our data, the fold changes of miR-217 and miR-532 in fibromyalgia patients were significantly lower than in controls, for miR-217 (median = 0.1359, IQR: 0.038 to 0.287, P < 0.001) and miR-532 [median = 0.2199, IQR: (0.114 to 0.421), P < 0.001].

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia

Study design awaiting verification · European Journal of Medical Research · 2025

Original publication title

Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia

Shymaa E. Ayoub; Azza M. Ahmed; Mostafa Y. Abdelwahed; Abeer A. Khalefa; Aeshah A. Awaji; Samer S. Zekry; Enas G. Ibrahim; Hana M. Eid; Shimaa M. Elasmer; Reham Fares

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

About 5% of the population suffers from fibromyalgia (FM), a chronic multi-symptom pain illness whose pathophysiology is still unknown. We aimed to be the first to investigate the possible association of sera levels of miR-217 and miR-532 in patients with fibromyalgia and correlate their expression levels to different clinical and biochemical disease criteria. This study included 80 participants who splitted into two groups: 40 fibromyalgia sufferers (12 male and 28 female), and 40 healthy volunteers (10 male and 30 female) who served as the control group.

Venous blood samples were collected from all subjects. The miR-217 and miR-532 serum expressions were detected using quantitative real-time PCR (qRT-PCR). According to our data, the fold changes of miR-217 and miR-532 in fibromyalgia patients were significantly lower than in controls, for miR-217 (median = 0.1359, IQR: 0.038 to 0.287, P < 0.001) and miR-532 [median = 0.2199, IQR: (0.114 to 0.421), P < 0.001]. In addition, there was a significant negative relationship between Aspartate transaminase (AST) and both miR-217 and miR-532 (r = − 0.480, P = P < 0.001 r = − 0.462, P = P < 0.001), respectively.

Serum miR-217 and miR-532 could serve as potential diagnostic biomarkers for fibromyalgia.

Authors’ abstract

About 5% of the population suffers from fibromyalgia (FM), a chronic multi-symptom pain illness whose pathophysiology is still unknown. We aimed to be the first to investigate the possible association of sera levels of miR-217 and miR-532 in patients with fibromyalgia and correlate their expression levels to different clinical and biochemical disease criteria. This study included 80 participants who splitted into two groups: 40 fibromyalgia sufferers (12 male and 28 female), and 40 healthy volunteers (10 male and 30 female) who served as the control group.

Venous blood samples were collected from all subjects. The miR-217 and miR-532 serum expressions were detected using quantitative real-time PCR (qRT-PCR). According to our data, the fold changes of miR-217 and miR-532 in fibromyalgia patients were significantly lower than in controls, for miR-217 (median = 0.1359, IQR: 0.038 to 0.287, P < 0.001) and miR-532 [median = 0.2199, IQR: (0.114 to 0.421), P < 0.001]. In addition, there was a significant negative relationship between Aspartate transaminase (AST) and both miR-217 and miR-532 (r = − 0.480, P = P < 0.001 r = − 0.462, P = P < 0.001), respectively.

Serum miR-217 and miR-532 could serve as potential diagnostic biomarkers for fibromyalgia.

Publication and source details

Original title: Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia

Shymaa E. Ayoub; Azza M. Ahmed; Mostafa Y. Abdelwahed; Abeer A. Khalefa; Aeshah A. Awaji; Samer S. Zekry; Enas G. Ibrahim; Hana M. Eid; Shimaa M. Elasmer; Reham Fares

European Journal of Medical Research · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Fayoum University

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:48:59.424501+00:00

DOI: 10.1186/s40001-025-02330-y · PMC11803959